Related Experiment Video
Updated: Aug 5, 2026

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
BAG3 modulates clathrin-mediated endocytosis and tau uptake in astrocytes
Joel Rodwell-Bullock1, Ella Blau1, Archan Ganguly2
1Department of Anesthesiology and Perioperative Medicine, University of Rochester, Rochester NY, 14620 USA.
Abstract:
In a healthy brain, astrocytes maintain neuronal homeostasis by removing proteins like tau from the extracellular space, preventing their uptake by neurons. In Alzheimer's disease (AD), this function is impaired, contributing to tau accumulation. Many AD risk genes are linked to endocytosis pathways, suggesting their role in AD pathogenesis. Astrocytes can internalize, degrade, and release tau, but the mechanisms remain unclear. BAG3, a multifunctional protein, regulates vacuolar processes and interacts with clathrin-mediated endocytosis (CME) components. However, its role in astrocytic CME and tau processing is not fully understood. We show BAG3 depletion in astrocytes reduces clathrin-AP-2 interaction, inhibits CME-dependent epidermal growth factor receptor internalization, and decreases tau uptake. Live-cell imaging reveals BAG3 depletion impairs CME dynamics, increasing clathrin particle lifetimes. BAG3 depletion also alters endolysosomal compartments, increasing Lamp1+ puncta and tau co-localization. These findings highlight BAG3's role in CME, tau trafficking, and vacuolar processes, suggesting its dysfunction may contribute to AD pathogenesis.
More Related Videos
09:12Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
Published on: December 20, 2019
10:38Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases
Published on: December 22, 2023